Navigation Links
Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
Date:12/20/2007

VANTAS(R) to be Only Once-Yearly Implant for Prostate Cancer in U.S. Market

Indevus Reaffirms Commitment to Prostate Cancer Patients

LEXINGTON, Mass., Dec. 20 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today commented on the announcement by Bayer Healthcare that they would discontinue marketing their product Viadur(R) (leuprolide acetate implant), which is indicated for the palliative treatment of advanced prostate cancer. As a result of this announcement, Indevus' product VANTAS(R) (histrelin implant) will be the only 12-month implant for the palliative treatment of advanced prostate cancer. Indevus remains committed to providing patients and physicians effective options for the treatment of advanced prostate cancer.

"Indevus is firmly committed to providing continuity of care for current Viadur patients," stated Kurt W. Lewis, senior vice president, sales and marketing of Indevus. "We will ensure that physicians have ready access to VANTAS, therefore enabling a smooth transition for those patients who desire a once-yearly therapy for the treatment of advanced prostate cancer."

"VANTAS is appropriate for patients who are candidates for long-term LHRH therapy," stated James E. Shipley, M.D., senior vice president clinical development and medical affairs of Indevus. "VANTAS provides the flexibility that only the technology of our once-yearly Hydron Implant can offer, resulting in improved patient compliance and physician efficiency."

More information regarding VANTAS is available at http://www.vantasimplant.com or by calling 888-282-5372.

About VANTAS

VANTAS(R) is a soft and flexible 12-month hydrogel impla
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Allergan as New Partner for SANCTURA Brand
3. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
4. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
5. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
6. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
7. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
8. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
9. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... consist of three large odour control systems for waste water ... "These orders are consistent with the market resurgence in ... President and CEO. "After a difficult period of restraint in ... to see sales growth. Our lower cost structure, technology improvements ...
(Date:9/1/2014)... 2014 Reportlinker.com announces that a new ... India Solid Waste Management Vehicles Market ... http://www.reportlinker.com/p02350445/India-Solid-Waste-Management-Vehicles-Market-Forecast-and-Opportunities-2019.html In India ... bodies responsible for complete handling and regulation of ... around 135,000 MT solid waste is generated daily ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 ... Industry” is a professional and in-depth research ... provides basic Polyacrylamide information, including Polyacrylamide definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
(Date:8/29/2014)... 2014 The global companion diagnostics ... 2019. It is expected to grow at a ... was valued at $1.8 billion in 2013, according ... Research. , For more information regarding analysis details ... The research report, titled “Companion Diagnostics Market (Breast ...
Breaking Biology Technology:India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 2India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 3India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 4India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 5India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 6India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 7India Solid Waste Management Vehicles Market Forecast and Opportunities, 2019 8International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 2International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 3Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3
... April 15 Vion,Pharmaceuticals, Inc. (Nasdaq: VION ) ... and sustain compliance with The Nasdaq Capital Market,listing requirements, ... Previously, the Company announced that it had received ... Market, Inc., notifying the Company,that it does not comply ...
... Inc.,(TSX: ONC, NASDAQ: ONCY) announced that an oral ... Cancer Centre, Calgary, entitled,"Targeting Multiple Myeloma with Oncolytic ... for Cancer Research (AACR) Annual,Meeting. The meeting is ... 2008., The presentation covered preclinical work using ...
... April 15 Phytomedics Inc., an,innovative clinical ... therapeutics from natural sources, today,announced that Dr. ... company as,its President and Chief Executive Officer. ... his retirement, but who will remain on ...
Cached Biology Technology:Vion Pharmaceuticals Files Plan With Nasdaq 2Vion Pharmaceuticals Files Plan With Nasdaq 3Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting 2Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer 2
(Date:9/2/2014)... study, led by researchers at the University of Warwick ... and just published in the Journal Early Human ... time spent in hospital after birth and the use ... ability in preterm children. , Mathematic abilities are crucial ... common in very preterm children. Earlier studies of children ...
(Date:9/2/2014)... issue of The FASEB Journal , ... the leading cause of blindness in adults, diabetic ... advance involves quantifying the early molecular changes caused ... Using new probes developed by scientists, they were ... diabetic retinopathy. , "My goal is to establish ...
(Date:9/2/2014)... your integrity? Tell the truth; everyone has a tipping point. ... we,ll lie if the benefit is great enough. Now, scientists ... make that decision. , The result was published online ... "We prefer to be honest, even if lying is beneficial," ... associate at the Virginia Tech Carilion Research Institute , ...
Breaking Biology News(10 mins):Mechanical ventilation a key indicator for pre-term children's math problems 2Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 4
... recent studies that suggest the use of stored blood during ... Lung, and Blood Institute (NHLBI) funded a number of research ... and the impact of stored blood on respiratory gases. These ... concerns for oxygen delivery by transfusion are now available online ...
... group has concluded that forests and other terrestrial ecosystems in ... of the nation,s fossil fuel carbon emissions, a larger amount ... disturbance occurs. Widespread droughts, such as those that occurred ... sequestered by about 20 percent, the scientists concluded in a ...
... of a calcium carbonate crystal, a simple mollusk may have ... Daniel Speiser, a postdoctoral fellow in the Department of Ecology ... that he collected in the Florida Keys. His research of ... resulted in a study published today by Current Biology ...
Cached Biology News:Safety of stored blood among chief concerns for transfusion medicine community 2Carbon sequestration estimate in US increased -- barring a drought 2Carbon sequestration estimate in US increased -- barring a drought 3Eyes of rock let chitons see predators 2
EDTA, disodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99.0-101.0%, nuclease-free.Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemi...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast...
The Proteome Profiler Human Phospho-MAPK Array Kit contains 4 membranes - each spotted in duplicate with 23 different MAPK antibodies....
Biology Products: